CUSIP: 38000Q102
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
38,695,728
-
Share change
-
-1,296,130
-
Total reported value
-
$145,493,534
-
Put/Call ratio
-
440%
-
Price per share
-
$3.76
-
Number of holders
-
88
-
Value change
-
+$615,055
-
Number of buys
-
51
-
Number of sells
-
32
Security key
38000Q102
Report period
Q4 2020
Institutions
88
Top holders
10
Reporting periods
Holder history for CUSIP 38000Q102
Recent filing periods:
Top shareholders of GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2020
As of 31 Dec 2020,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,695,728 shares.
The largest 10 holders included
BVF INC/IL, NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, DIMENSIONAL FUND ADVISORS LP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2020 vs Q3 2020 Across Filers
| Investor |
Q3 2020 Shares |
Q4 2020 Shares |
Share Diff |
Share Chg % |
Q3 2020 Value $ |
Q4 2020 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.